Abstract

Medicaid, the state-level public insurance in the United States, has widely differing criteria treatment for hepatitis C virus (HCV) such as stage of liver fibrosis, documented sobriety, and specialist consultation. In a rural health network, facilities located in two less restrictive states prescribed HCV drugs at a significantly higher rate than two more restrictive states (rate ratio 4.7, CI 2.6–8.5). Prescription rates per population were highly associated with HCV treatment policies.

Details

Title
Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018
Author
Reilley, Brigg; Miller, Matt; Hudson, Matt; Haverkate, Rick; Leston, Jessica
Pages
1-3
Section
Letter to the Editor
Publication year
2019
Publication date
2019
Publisher
BioMed Central
e-ISSN
14759276
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1186/s12939-019-1101-4
ProQuest document ID
2328432458
Copyright
© 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.